Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review

N Zaki, H Alashwal, S Ibrahim - … & Metabolic Syndrome: Clinical Research & …, 2020 - Elsevier
Background and aims To undertake a review and critical appraisal of published/preprint
reports that offer methods of determining the effects of hypertension, diabetes, stroke …

Secondary attack rate of COVID-19 in household contacts: a systematic review

K Shah, D Saxena, D Mavalankar - QJM: An International …, 2020 - academic.oup.com
Summary Coronavirus disease 2019 (COVID-19) is a novel virus with continuously evolving
transmission trends. Contact tracing and quarantining of positive cases are chief strategies …

Conflicts over calcium and the treatment of COVID-19

B Crespi, J Alcock - Evolution, Medicine, and Public Health, 2021 - academic.oup.com
Several recent studies have provided evidence that use of calcium channel blockers
(CCBs), especially amlodipine and nifedipine, can reduce mortality from coronavirus …

[HTML][HTML] Lack of association of antihypertensive drugs with the risk and severity of COVID-19: a meta-analysis

L Ren, S Yu, W Xu, JL Overton, N Chiamvimonvat… - Journal of …, 2021 - Elsevier
Background The association of antihypertensive drugs with the risk and severity of COVID-
19 remains unknown. Methods and Results We systematically searched PubMed …

COVID‐19 patients with documented alcohol use disorder or alcohol‐related complications are more likely to be hospitalized and have higher all‐cause mortality

KL Bailey, H Sayles, J Campbell… - Alcoholism: Clinical …, 2022 - Wiley Online Library
Abstract Background Coronavirus Disease 2019 (COVID‐19) has affected every country
globally, with hundreds of millions of people infected with the SARS‐CoV‐2 virus and over 6 …

Risk of incident new-onset arterial hypertension after COVID-19 recovery: a systematic review and meta-analysis

M Zuin, G Rigatelli, C Bilato, G Pasquetto… - High Blood Pressure & …, 2023 - Springer
Abstract Introduction Arterial Hypertension (HT) has been described as a common
comorbidity and independent risk factor of short-term outcome in COVID-19 patients …

Hypertension is a risk factor for adverse outcomes in patients with coronavirus disease 2019: a cohort study

TY **ong, FY Huang, Q Liu, Y Peng, YN Xu… - Annals of …, 2020 - Taylor & Francis
Background Comorbidities are commonly seen in patients with coronavirus disease 2019
(COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the …

The age structure, stringency policy, income, and spread of coronavirus disease 2019: evidence from 209 countries

F Bilgili, M Dundar, S Kuşkaya, DB Lorente… - Frontiers in …, 2021 - frontiersin.org
This article aims at answering the following questions:(1) What is the influence of age
structure on the spread of coronavirus disease 2019 (COVID-19)?(2) What can be the …

[HTML][HTML] A pilot study: Exploring the influence of COVID-19 on cardiovascular physiology and retinal microcirculation

A Saloň, R Neshev, K Teraž, B Šimunič, M Peskar… - Microvascular …, 2023 - Elsevier
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the
cardiovascular system. The current study investigated changes in heart rate (HR), blood …

[HTML][HTML] State-of-the-art review: hypertension practice guidelines in the era of COVID-19

KC Ferdinand, TN Vo, MR Echols - American journal of preventive …, 2020 - Elsevier
The global burden of hypertension (HTN) is immense and increasing. In fact, HTN is the
leading risk factor for adverse cardiovascular disease outcomes. Due to the critical …